Therapeutic cell encapsulation: Ten steps towards clinical translation

Journal of Controlled Release

Volumn 170, Issue 1, 2013, Pages 1-14

  Santos, Edorta ^a,b   Pedraz, José Luis ^a,b   Hernández, Rosa María ^a,b   Orive, Gorka ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Cell encapsulation; Cell therapy; Clinic; Drug delivery; Stem cells

Indexed keywords

BIOMIMETICS; BIOTECHNOLOGY; CELLS; COST EFFECTIVENESS; DRUG DELIVERY; STEM CELLS;

BIOFUNCTIONALIZATION; CELL ENCAPSULATIONS; CELL MICROENCAPSULATION; CELL THERAPY; CLINIC; CLINICAL TRANSLATION; IMMUNOMODULATORY EFFECTS; TRANSPLANTED CELLS;

CYTOLOGY;

AGAROSE; ALGINIC ACID; BIOMATERIAL; CALCIUM ALGINATE; CHITOSAN; COLLAGEN; FIBRIN; HYALURONIC ACID; MACROGOL; POLYCATION; POLYLYSINE; POLYMER; POLYORNITHINE;

BIOCOMPATIBILITY; BIOMIMETICS; BIOSAFETY; BIOTECHNOLOGY; CELL ENCAPSULATION; CELL FUNCTION; CELL HOMING; CELL TRANSPLANTATION; CROSS LINKING; DEGRADATION KINETICS; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; HYDROGEL; IMMOBILIZED CELL; IMMUNOGENICITY; IMMUNOMODULATION; MATERIAL COATING; MESENCHYMAL STEM CELL; MICROCAPSULE; MICROENCAPSULATION; MICROENVIRONMENT; MULTIPOTENT STEM CELL; NERVE CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REPORTER GENE; REVIEW; SERTOLI CELL; STEM CELL; STROMA CELL; SUICIDE GENE;

EID: 84878247769     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.04.015     Document Type: Review

References (195)

1. M.S. Shoichet, S.R. Winn, Cell delivery to the central nervous system, Adv. Drug Deliv. Rev. 42 (2000) 81-102. (Pubitemid 30609636)
2. T.M.S. Chang, Semipermeable microcapsules, Science 146 (1964) 524-525.
3. G. Orive, R.M. Hernandez, A.R. Gascon, R. Calafiore, T.M. Chang, P. De Vos, G. Hortelano, D. Hunkeler, I. Lacik, A.M. Shapiro, J.L. Pedraz, Cell encapsulation: promise and progress, Nat. Med. 9 (2003) 104-107. (Pubitemid 36098269)
4. F. Lim, A. Sun, Microencapsulated islets as bioartificial endocrine pancreas, Science 210 (1980) 908-910. (Pubitemid 11169847)
5. S.K. Tam, S. Bilodeau, J. Dusseault, G. Langlois, J.P. Halle, L.H. Yahia, Biocompatibility and physicochemical characteristics of alginate-polycation microcapsules, Acta Biomater. 7 (2011) 1683-1692.
6. D.R. Arifin, S. Manek, E. Call, A. Arepally, J.W.M. Bulte, Microcapsules with intrinsic barium radiopacity for immunoprotection and X-ray/CT imaging of pancreatic islet cells, Biomaterials 33 (2012) 4681-4689.
7. E. Santos, R.M. Hernandez, J.L. Pedraz, G. Orive, Novel advances in the design of three-dimensional bio-scaffolds to control cell fate: translation from 2D to 3D, Trends Biotechnol. 30 (2012) 331-341.
8. G. Basta, P. Montanucci, G. Luca, C. Boselli, G. Noya, B. Barbaro,M. Qi, K.P. Kinzer, J. Oberholzer, R. Calafiore, Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases, Diabetes Care 34 (2011) 2406-2409.
9. B.E. Tuch, G.W. Keogh, L.J. Williams, W. Wu, J.L. Foster, V. Vaithilingam, R. Philips, Safety and viability of microencapsulated human islets transplanted into diabetic humans, Diabetes Care 32 (2009) 1887-1889.
10. R.B. Elliott, L. Escobar, P.L.J. Tan,M.Muzina, S. Zwain, C. Buchanan, Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation, Xenotransplantation 14 (2007) 157-161. (Pubitemid 46457454)
11. R.E. Gross, R.L. Watts, R.A. Hauser, R.A. Bakay, H. Reichmann, R. von Kummer, W.G. Ondo, E. Reissig, W. Eisner, H. Steiner-Schulze, H. Siedentop, K. Fichte, W. Hong, M. Cornfeldt, K. Beebe, R. Sandbrink, Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial, Lancet Neurol. 10 (2011) 509-519.
12. C. Hasse, G. Klöck, A. Schlosser, U. Zimmermann, M. Rothmund, Parathyroid allotransplantation without immunosuppression, Lancet 350 (1997) 1296-1297.
13. P. Aebischer, M. Schluep, N. Deglon, J.M. Joseph, L. Hirt, B. Heyd, M. Goddard, J.P. Hammang, A.D. Zurn, A.C. Kato, F. Regli, E.E. Baetge, Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients, Nat. Med. 2 (1996) 696-699. (Pubitemid 26191960)
14. M. Lohr, A. Hoffmeyer, J. Kroger, M. Freund, J. Hain, A. Holle, P. Karle, W.T. Knofel, S. Liebe, P. Muller, H. Nizze, M. Renner, R.M. Saller, T. Wagner, K. Hauenstein, W.H. Gunzburg, B. Salmons, Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma, Lancet 357 (2001) 1591-1592. (Pubitemid 32488821)
15. K.E. Talcott, K. Ratnam, S.M. Sundquist, A.S. Lucero, B.J. Lujan, W. Tao, T.C. Porco, A. Roorda, J.L. Duncan, Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment, Investig. Ophthalmol. Vis. Sci. 52 (2011) 2219-2226.
16. P. de Vos, M. Spasojevic, B.J. de Haan, M.M. Faas, The association between in vivo physicochemical changes and inflammatory responses against alginate based microcapsules, Biomaterials 33 (2012) 5552-5559.
17. J. Bloch, A.C. Bachoud-Levi, N. Deglon, J.P. Lefaucheur, L. Winkel, S. Palfi, J.P. Nguyen, C. Bourdet, V. Gaura, P. Remy, P. Brugieres, M.F. Boisse, S. Baudic, P. Cesaro, P. Hantraye, P. Aebischer, M. Peschanski, Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study, Hum. Gene Ther. 15 (2004) 968-975. (Pubitemid 39372573)
18. A. Acarregui, A. Murua, J.L. Pedraz, G. Orive, R.M. Hernández, A perspective on bioactive cell microencapsulation, BioDrugs 26 (2012) 283-301.
19. G. Karoubi, M.L. Ormiston, D.J. Stewart, D.W. Courtman, Single-cell hydrogel encapsulation for enhanced survival of human marrow stromal cells, Biomaterials 30 (2009) 5445-5455.
20. J.A. Burdick, G.D. Prestwich, Hyaluronic acid hydrogels for biomedical applications, Adv. Mater. 23 (2011) H41-H56.
21. S.B. Anderson, C. Lin, D.V. Kuntzler, K.S. Anseth, The performance of humanmesenchymal stem cells encapsulated in cell-degradable polymer-peptide hydrogels, Biomaterials 32 (2011) 3564-3574.
22. C.L. Hastings, H.M. Kelly, M.J. Murphy, F.P. Barry, F.J. O'Brien, G.P. Duffy, Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia, J. Control. Release 161 (2012) 73-80.
23. B.P. Chan, T.Y. Hui, C.W. Yeung, J. Li, I. Mo, G.C. Chan, Self-assembled collagenhumanmesenchymal stemcell microspheres for regenerativemedicine, Biomaterials 28 (2007) 4652-4666. (Pubitemid 47260704)
24. J. Liu, H. Zhou, M.D. Weir, H.H. Xu, Q. Chen, C.A. Trotman, Fast-degradable microbeads encapsulating human umbilical cord stem cells in alginate for muscle tissue engineering, Tissue Eng. A 18 (2012) 2303-2314.
25. E. Santos, J. Zarate, G. Orive, R.M. Hernandez, J.L. Pedraz, Biomaterials in cell microencapsulation, Adv. Exp. Med. Biol. 670 (2010) 5-21.
26. K.Y. Lee, D.J. Mooney, Alginate: Properties and biomedical applications, Prog. Polym. Sci. 37 (2012) 106-126.
27. R.T. Kershen, S.D. Fefer, A. Atala, Tissue-engineered therapies for the treatment of urinary incontinence and vesicoureteral reflux,World J. Urol. 18 (2000) 51-55.
28. G. Orive, S. Ponce, R.M. Hernandez, A.R. Gascon, M. Igartua, J.L. Pedraz, Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates, Biomaterials 23 (2002) 3825-3831. (Pubitemid 34828156)
29. A.M. Rokstad, O. Brekke, B. Steinkjer, L. Ryan, G. Kollá riková, B.L. Strand, G. Skjåk-Bræk, I. Lacík, T. Espevik, T.E. Mollnes, Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model, Acta Biomater. 7 (2011) 2566-2578.
30. R.M. Hernández, G. Orive, A. Murua, J.L. Pedraz, Microcapsules and microcarriers for in situ cell delivery, Adv. Drug Deliv. Rev. 62 (2010) 711-730.
31. H. Kong, K.Y. Lee, D.J. Mooney, Decoupling the dependence of rheological/ mechanical properties of hydrogels from solids concentration, Polymer 43 (2002) 6239-6246.
32. Y.A. Mørch, I. Donati, B.L. Strand, G. Skjåk-Braek, Molecular engineering as an approach to design new functional properties of alginate, Biomacromolecules 8 (2007) 2809-2814. (Pubitemid 47520445)
33. Y.A.Mørch, S. Holtan, I.Donati, B.L. Strand, G. Skjåk-Braek,Mechanical properties of C-5 epimerized alginates, Biomacromolecules 9 (2008) 2360-2368.
34. U. Remminghorst, B.A. Rehm, Bacterial alginates: from biosynthesis to applications, Biotechnol. Lett. 28 (2006) 1701-1712. (Pubitemid 44454893)
35. S. Sakai, H. Inagaki, K. Inamoto, M. Taya, Wrapping tissues with a pre-established cage-like layer composed of living cells, Biomaterials 33 (2012) 6721-6727.
36. K. Ma, A.L. Titan, M. Stafford, C.h. Zheng, M.E. Levenston, Variations in chondrogenesis of human bone marrow-derived mesenchymal stem cells in fibrin/alginate blended hydrogels, Acta Biomater. 8 (2012) 3754-3764.
37. Y.A. Mørch, I. Donati, B.L. Strand, G. Skjåk-Braek, Effect of Ca2+, Ba2+, and Sr2+ on alginate microbeads, Biomacromolecules 7 (2006) 1471-1480.
38. B. Thu, P. Bruheim, T. Espevik, O. Smidsrod, P. Soon-Shiong, G. Skjak-Braek, Alginate polycation microcapsules. I. Interaction between alginate and polycation, Biomaterials 17 (1996) 1031-1040. (Pubitemid 26160068)
39. Y. Suzuki, Y. Nishimura, M. Tanihara, K. Suzuki, T. Nakamura, Y. Shimizu, Y. Yamawaki, Y. Kakimaru, Evaluation of a novel alginate gel dressing: cytotoxicity to fibroblasts in vitro and foreign-body reaction in pig skin in vivo, J. Biomed. Mater. Res. 39 (1998) 317-322. (Pubitemid 28060366)
40. O. Jeon, K.H. Bouhadir, J.M. Mansour, E. Alsberg, Photocrosslinked alginate hydrogels with tunable biodegradation rates and mechanical properties, Biomaterials 30 (2009) 2724-2734.
41. K.A. Smeds, M.W. Grinstaff, Photocrosslinkable polysaccharides for in situ hydrogel formation, J. Biomed. Mater. Res. 54 (2001) 115-121.
42. S. Sakai, K. Kawakami, Synthesis and characterization of both ionically and enzymatically cross-linkable alginate, Acta Biomater. 3 (2007) 495-501. (Pubitemid 46865779)
43. L.S. Teixeira, J. Feijen, C.A. van Blitterswijk, P.J. Dijkstra, M. Karperien, Enzyme-catalyzed crosslinkable hydrogels: emerging strategies for tissue engineering, Biomaterials 33 (2012) 1281-1290.
44. R. Jin, L.S. Moreira Teixeira, P.J. Dijkstra, C.A. van Blitterswijk, M. Karperien, J. Feijen, Chondrogenesis in injectable enzymatically crosslinked heparin/dextran hydrogels, J. Control. Release 152 (2011) 186-195.
45. J. Sun, X. Zhao, W.R.K. Illeperuma, O. Chaudhuri, K.H. Oh, D.J. Mooney, J.J. Vlassak, Z. Suo, Highly stretchable and tough hydrogels, Nature 489 (2012) 133-136.
46. H.J. Kong, E. Wong, D.J. Mooney, Independent control of rigidity and toughness of polymeric hydrogels, Macromolecules 36 (2003) 4582-4588.
47. E.H. Nafea, A. Marson, L.A. Poole-Warren, P.J. Martens, Immunoisolating semi-permeable membranes for cell encapsulation: focus on hydrogels, J. Control. Release 154 (2011) 110-122.
48. P. de Vos, M. Bucko, P. Gemeiner, M. Navratil, J. Svitel, M. Faas, B.L. Strand, G. Skjak-Braek, Y.A. Morch, A. Vikartovska, I. Lacik, G. Kollarikova, G. Orive, D. Poncelet, J.L. Pedraz, M.B. Ansorge-Schumacher, Multiscale requirements for bioencapsulation in medicine and biotechnology, Biomaterials 30 (2009) 2559-2570.
49. Y.Ma, Y. Zhang, Y.Wang, Q. Wang,M. Tan, Y. Liu, L. Chen, N. Li,W. Yu, X.Ma, Study of the effect of membrane thickness on microcapsule strength, permeability, and cell proliferation, J. Biomed. Mater. Res. A (2012), http://dx.doi.org/10.1002/ jbm.a.34395.
50. G. Orive, R.M. Hernandez, A.R. Gascon, M. Igartua, J.L. Pedraz, Encapsulated cell technology: from research to market, Trends Biotechnol. 20 (2002) 382-387. (Pubitemid 34880173)
51. G. Orive, R.M. Hernandez, A.R. Gascon, M. Igartua, J.L. Pedraz, Development and optimisation of alginate-PMCG-alginate microcapsules for cell immobilisation, Int. J. Pharm. 259 (2003) 57-68. (Pubitemid 36638554)
52. L. Baruch, M. Machluf, Alginate-chitosan complex coacervation for cell encapsulation: effect on mechanical properties and on long-term viability, Biopolymers 82 (2006) 570-579. (Pubitemid 44204795)
53. T. Haque, H. Chen, W. Ouyang, C. Martoni, B. Lawuyi, A.M. Urbanska, S. Prakash, In vitro study of alginate-chitosan microcapsules: an alternative to liver cell transplants for the treatment of liver failure, Biotechnol. Lett. 27 (2005) 317-322. (Pubitemid 40564454)
54. M. De Castro, G. Orive, R.M. Hernandez, A. Bartkowiak, W. Brylak, J.L. Pedraz, Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules, J. Biomed. Mater. Res. A 91 (2009) 1119-1130.
55. E. Marsich, M. Borgogna, I. Donati, P. Mozetic, B.L. Strand, S.G. Salvador, F. Vittur, S. Paoletti, Alginate/lactose-modified chitosan hydrogels: a bioactive biomaterial for chondrocyte encapsulation, J. Biomed. Mater. Res. A 84 (2008) 364-376.
56. B. Baroli, Photopolymerization of biomaterials: issues and potentialities in drug delivery, tissue engineering, and cell encapsulation applications, J. Chem. Technol. Biotechnol. 81 (2006) 491-499.
57. A. Leung, M. Trau, L.K. Nielsen, Assembly of multilayer PSS/PAH membrane on coherent alginate/PLOmicrocapsule for long-termgraft transplantation, J. Biomed. Mater. Res. A 88 (2009) 226-237.
58. A. Paul, A. Cantor, D. Shum-Tim, S. Prakash, Superior cell delivery features of genipin crosslinked polymeric microcapsules: preparation, in vitro characterization and pro-angiogenic applications using human adipose stem cells, Mol. Biotechnol. 48 (2011) 116-127.
59. A. Leung, L.K. Nielsen, M. Trau, N.E. Timmins, Tissue transplantation by stealth-coherent alginate microcapsules for immunoisolation, Biochem. Eng. J. 48 (2010) 337-347.
60. J.M. Anderson, A. Rodriguez, D.T. Chang, Foreign body reaction to biomaterials, Semin. Immunol. 20 (2008) 86-100.
61. C.G. van Hoogmoed, H.J. Busscher, P. de Vos, Fourier transform infrared spectroscopy studies of alginate-PLL capsules with varying compositions, J. Biomed. Mater. Res. A 67 (2003) 172-178. (Pubitemid 37517166)
62. P. de Vos, C.G. van Hoogmoed, J. van Zanten, S. Netter, J.H. Strubbe, H.J. Busscher, Long-term biocompatibility, chemistry, and function of microencapsulated pancreatic islets, Biomaterials 24 (2003) 305-312. (Pubitemid 35292574)
63. J. Wikström, M. Elomaa, L. Nevala, J. Räikkönen, P. Heljo, A. Urtti, M. Yliperttula, Viability of freeze dried microencapsulated human retinal pigment epithelial cells, Eur. J. Pharm. Sci. 47 (2012) 520-526.
64. Y.Ma, Y. Zhang, Y. Liu, L. Chen, S. Li,W. Zhao, G. Sun, N. Li, Y.Wang, X. Guo, G. Lv, X. Ma, Investigation of alginate-ε-poly-L-lysine microcapsules for cell microencapsulation, J. Biomed. Mater. Res. A (2012), http://dx.doi.org/10.1002/jbm.a.34418.
65. J. Jin, M. Song, D.J. Hourston, Novel chitosan-based films cross-linked by genipin with improved physical properties, Biomacromolecules 5 (2004) 162-168. (Pubitemid 38181326)
66. A.L. Hillberg, C.A. Holmes, M. Tabrizian, Effect of genipin cross-linking on the cellular adhesion properties of layer-by-layer assembled polyelectrolyte films, Biomaterials 30 (2009) 4463-4470.
67. A.L. Hillberg, K. Kathirgamanathan, J.B. Lam, L.Y. Law, O. Garkavenko, R.B. Elliott, Improving alginate-poly-L-ornithine-alginate capsule biocompatibility through genipin crosslinking, J. Biomed.Mater. Res. B Appl. Biomater. 101 (2012) 258-268.
68. C. Wang, T.T. Lau, W.L. Loh, K. Su, D. Wang, Cytocompatibility study of a natural biomaterial crosslinker-Genipin with therapeutic model cells, J. Biomed. Mater. Res. B Appl. Biomater. 97B (2011) 58-65.
69. H. Chen, W. Ouyang, M. Jones, T. Metz, C. Martoni, T. Haque, R. Cohen, B. Lawuyi, S. Prakash, Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy, Cell Biochem. Biophys. 47 (2007) 159-167. (Pubitemid 46570707)
70. P. de Vos, B.J. de Haan, J.A.A.M. Kamps, M.M. Faas, T. Kitano, Zeta-potentials of alginate-PLL capsules: A predictive measure for biocompatibility? J. Biomed. Mater. Res. A 80A (2007) 813-819.
71. B.J. de Haan, A. Rossi, M.M. Faas, M.J. Smelt, F. Sonvico, P. Colombo, P. de Vos, Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid, J. Biomed. Mater. Res. A 98 (2011) 394-403.
72. S.K. Tam, J. Dusseault, S. Bilodeau, G. Langlois, J.P. Halle, L. Yahia, Factors influencing alginate gel biocompatibility, J. Biomed. Mater. Res. A 98 (2011) 40-52.
73. P. de Vos, C.G. van Hoogmoed, B.J. de Haan, H.J. Busscher, Tissue responses against immunoisolating alginate-PLL capsules in the immediate posttransplant period, J. Biomed. Mater. Res. 62 (2002) 430-437. (Pubitemid 35332207)
74. J. Zheng, H. Xie, W. Yu, M. Tan, F. Gong, X. Liu, F. Wang, G. Lv, W. Liu, G. Zheng, Y. Yang, W. Xie, X. Ma, Enhancement of surface graft density of MPEG on alginate/chitosan hydrogel microcapsules for protein repellency, Langmuir 28 (2012) 13261-13273.
75. J.N. Zheng, H.G. Xie, W.T. Yu, X.D. Liu, W.Y. Xie, J. Zhu, X.J. Ma, Chitosan-g-MPEG-modified alginate/chitosan hydrogel microcapsules: a quantitative study of the effect of polymer architecture on the resistance to protein adsorption, Langmuir 26 (2010) 17156-17164.
76. Y. Xu, M. Takai, K. Ishihara, Suppression of protein adsorption on a charged phospholipid polymer interface, Biomacromolecules 10 (2009) 267-274.
77. Y. Goto, R. Matsuno, T. Konno, M. Takai, K. Ishihara, Polymer nanoparticles covered with phosphorylcholine groups and immobilized with antibody for high-affinity separation of proteins, Biomacromolecules 9 (2008) 828-833. (Pubitemid 351560472)
78. N.B. Holland, Y. Qiu, M. Ruegsegger, R.E. Marchant, Biomimetic engineering of non-adhesive glycocalyx-like surfaces using oligosaccharide surfactant polymers, Nature 392 (1998) 799-801. (Pubitemid 28225316)
79. R.W. Sands, D.J. Mooney, Polymers to direct cell fate by controlling the microenvironment, Curr. Opin. Biotechnol. 18 (2007) 448-453. (Pubitemid 350116593)
80. G. Orive, M. De Castro, H.J. Kong, R.M. Hernandez, S. Ponce, D.J. Mooney, J.L. Pedraz, Bioactive cell-hydrogel microcapsules for cell-based drug delivery, J. Control. Release 135 (2009) 203-210.
81. K.Y. Lee, H.J. Kong, R.G. Larson, D.J. Mooney, Hydrogel formation via cell crosslinking, Adv. Mater. 15 (2003) 1828-1832.
82. T.A. Ahmed, E.V. Dare, M. Hincke, Fibrin: a versatile scaffold for tissue engineering applications, Tissue Eng. B Rev. 14 (2008) 199-215. (Pubitemid 351839214)
83. D.F.Williams, The role of short synthetic adhesion peptides in regenerativemedicine; The debate, Biomaterials 32 (2011) 4195-4197.
84. S.L. Bellis, Advantages of RGD peptides for directing cell association with biomaterials, Biomaterials 32 (2011) 4205-4210.
85. A.Woods, J.R. Couchman, S. Johansson, M. Hook, Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments, EMBO J. 5 (1986) 665-670.
86. S. Aota, T. Nagai, K.M. Yamada, Characterization of regions of fibronectin besides the arginine-glycine-aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis, J. Biol. Chem. 266 (1991) 15938-15943. (Pubitemid 21907747)
87. A. Hautanen, J. Gailit, D.M. Mann, E. Ruoslahti, Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor, J. Biol. Chem. 264 (1989) 1437-1442. (Pubitemid 19050980)
88. J.C. Friedland, M.H. Lee, D. Boettiger, Mechanically activated integrin switch controls alpha5beta1 function, Science 323 (2009) 642-644.
89. Y. Mao, J.E. Schwarzbauer, Accessibility to the fibronectin synergy site in a 3D matrix regulates engagement of α 5β 1 versus α vβ 3 integrin receptors, Cell Commun. Adhes. 13 (2006) 267-277. (Pubitemid 44895999)
90. S.E. Ochsenhirt, E. Kokkoli, J.B. McCarthy, M. Tirrell, Effect of RGD secondary structure and the synergy site PHSRN on cell adhesion, spreading and specific integrin engagement, Biomaterials 27 (2006) 3863-3874.
91. D.J. Mooney, H. Vandenburgh, Cell delivery mechanisms for tissue repair, Cell Stem Cell 2 (2008) 205-213. (Pubitemid 351298597)
92. B. Trappmann, J.E. Gautrot, J.T. Connelly, D.G.T. Strange, Y. Li, M.L. Oyen,M.A. Cohen Stuart, H. Boehm, B. Li, V. Vogel, J.P. Spatz, F.M. Watt,W.T.S. Huck, Extracellularmatrix tethering regulates stem-cell fate, Nat. Mater. 11 (2012) 642-649.
93. N. Huebsch, P.R. Arany, A.S. Mao, D. Shvartsman, O.A. Ali, S.A. Bencherif, J. Rivera-Feliciano, D.J. Mooney, Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate, Nat. Mater. 9 (2010) 518-526.
94. J. Yu, K.T. Du, Q. Fang, Y. Gu, S.S. Mihardja, R.E. Sievers, J.C. Wu, R.J. Lee, The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat, Biomaterials 31 (2010) 7012-7020.
95. M. Grellier, P.L. Granja, J.C. Fricain, S.J. Bidarra, M. Renard, R. Bareille, C. Bourget, J. Amedee, M.A. Barbosa, The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect, Biomaterials 30 (2009) 3271-3278.
96. O. Tsur-Gang, E. Ruvinov, N. Landa, R. Holbova, M.S. Feinberg, J. Leor, S. Cohen, The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction, Biomaterials 30 (2009) 189-195.
97. A.R. Reynolds, I.R. Hart, A.R. Watson, J.C. Welti, R.G. Silva, S.D. Robinson, G. Da Violante, M. Gourlaouen, M. Salih, M.C. Jones, D.T. Jones, G. Saunders, V. Kostourou, F. Perron-Sierra, J.C. Norman, G.C. Tucker, K.M. Hodivala-Dilke, Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors, Nat. Med. 15 (2009) 392-400.
98. J.A. Rowley, G. Madlambayan, D.J. Mooney, Alginate hydrogels as synthetic extracellular matrix materials, Biomaterials 20 (1999) 45-53. (Pubitemid 29002544)
99. K.Y. Lee, E. Alsberg, S. Hsiong, W. Comisar, J. Linderman, R. Ziff, D. Mooney, Nanoscale adhesion ligand organization regulates osteoblast proliferation and differentiation, Nano Lett. 4 (2004) 1501-1506. (Pubitemid 39186338)
100. K.M. Hennessy, W.C. Clem, M.C. Phipps, A.A. Sawyer, F.M. Shaikh, S.L. Bellis, The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials, Biomaterials 29 (2008) 3075-3083.
101. A.A. Sawyer, K.M. Hennessy, S.L. Bellis, Regulation of mesenchymal stem cell attachment and spreading on hydroxyapatite by RGD peptides and adsorbed serum proteins, Biomaterials 26 (2005) 1467-1475. (Pubitemid 39441379)
102. S.X. Hsiong, T. Boontheekul, N. Huebsch, D.J. Mooney, Cyclic arginine-glycineaspartate peptides enhance three-dimensional stem cell osteogenic differentiation, Tissue Eng. A 15 (2009) 263-272.
103. O. Jeon, C. Powell, L.D. Solorio, M.D. Krebs, E. Alsberg, Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels, J. Control. Release 154 (2011) 258-266.
104. C. Yang, P.D. Mariner, J.N. Nahreini, K.S. Anseth, Cell-mediated delivery of glucocorticoids from thiol-ene hydrogels, J. Control. Release 162 (2012) 612-618.
105. J.A.Hubbell, S.N. Thomas,M.A. Swartz,Materials engineering for immunomodulation, Nature 462 (2009) 449-460.
106. C.Y. Cheung, K.S. Anseth, Synthesis of immunoisolation barriers that provide localized immunosuppression for encapsulated pancreatic islets, Bioconjug. Chem. 17 (2006) 1036-1042. (Pubitemid 44162624)
107. T.M. Kauer, J.L. Figueiredo, S. Hingtgen, K. Shah, Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas, Nat. Neurosci. 15 (2011) 197-204.
108. H. Kim, M.J. Cooke, M.S. Shoichet, Creating permissive microenvironments for stem cell transplantation into the central nervous system, Trends Biotechnol. 30 (2012) 55-63.
109. J.J. Moon, J.E. Saik, R.A. Poche, J.E. Leslie-Barbick, S.H. Lee, A.A. Smith, M.E. Dickinson, J.L. West, Biomimetic hydrogels with pro-angiogenic properties, Biomaterials 31 (2010) 3840-3847.
110. H.J. Kong, E. Alsberg, D. Kaigler, K.Y. Lee, D.J. Mooney, Controlling degradation of hydrogels via the size of crosslinked junctions, Adv. Mater. 16 (2004) 1917-1921.
111. T. Boontheekul, H.J. Kong, D.J. Mooney, Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution, Biomaterials 26 (2005) 2455-2465. (Pubitemid 39600698)
112. T. Boontheekul, E.E. Hill, H.J. Kong, D.J. Mooney, Regulating myoblast phenotype through controlled gel stiffness and degradation, Tissue Eng. 13 (2007) 1431-1442. (Pubitemid 47105752)
113. O. Jeon, D.S. Alt, S.M. Ahmed, E. Alsberg, The effect of oxidation on the degradation of photocrosslinkable alginate hydrogels, Biomaterials 33 (2012) 3503-3514.
114. H. Zhou, H.H.K. Xu, The fast release of stem cells fromalginate-fibrin microbeads in injectable scaffolds for bone tissue engineering, Biomaterials 32 (2011) 7503-7513.
115. M.W. Tibbitt, K.S. Anseth, Hydrogels as extracellular matrix mimics for 3D cell culture, Biotechnol. Bioeng. 103 (2009) 655-663.
116. M.P. Lutolf, J.L. Lauer-Fields, H.G. Schmoekel, A.T. Metters, F.E. Weber, G.B. Fields, J.A. Hubbell, Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5413-5418. (Pubitemid 36542719)
117. M.P. Lutolf, Integration column: artificial ECM: expanding the cell biology toolbox in 3D, Integr. Biol. (Camb.) 1 (2009) 235-241.
118. K.B. Fonseca, S.J. Bidarra,M.J. Oliveira, P.L. Granja, C.C. Barrias,Molecularly designed alginate hydrogels susceptible to local proteolysis as three-dimensional cellular microenvironments, Acta Biomater. 7 (2011) 1674-1682.
119. C.N. Salinas, B.B. Cole, A.M. Kasko, K.S. Anseth, Chondrogenic differentiation potential of human mesenchymal stem cells photoencapsulated within poly(ethylene glycol)-arginine-glycine-aspartic acid-serine thiol-methacrylate mixed-mode networks, Tissue Eng. 13 (2007) 1025-1034. (Pubitemid 46870427)
120. C. Adelow, T. Segura, J.A. Hubbell, P. Frey, The effect of enzymatically degradable poly(ethylene glycol) hydrogels on smooth muscle cell phenotype, Biomaterials 29 (2008) 314-326. (Pubitemid 350060978)
121. M.P. Zanin, L.N. Pettingill, A.R. Harvey, D.F. Emerich, C.G. Thanos, R.K. Shepherd, The development of encapsulated cell technologies as therapies for neurological and sensory diseases, J. Control. Release 160 (2012) 3-13.
122. G. Chan, D.J. Mooney, New materials for tissue engineering: towards greater control over the biological response, Trends Biotechnol. 26 (2008) 382-392.
123. B. Salmons, E.M. Brandtner, K. Hettrich, W. Wagenknecht, B. Volkert, S. Fischer, J.A. Dangerfield, W.H. Gunzburg, Encapsulated cells to focus the metabolic activation of anticancer drugs, Curr. Opin. Mol. Ther. 12 (2010) 450-460.
124. E. Piller Puicher, R. Tomanin, M. Salvalaio, A. Friso, G. Hortelano, O. Marin, M. Scarpa, Encapsulated engineered myoblasts can cure Hurler syndrome: preclinical experiments in the mouse model, Gene Ther. 19 (2012) 355-364.
125. F. Yang, X. Zhang, A. Maiseyeu, G. Mihai, R. Yasmeen, D. DiSilvestro, S.K. Maurya, M. Periasamy, K.V. Bergdall, G. Duester, C.K. Sen, S. Roy, L.J. Lee, S. Rajagopalan, O. Ziouzenkova, The prolonged survival of fibroblasts with forced lipid catabolism in visceral fat following encapsulation in alginate-poly-L-lysine, Biomaterials 33 (2012) 5638-5649.
126. M. de Groot, T.A. Schuurs, R. van Schilfgaarde, Causes of limited survival of microencapsulated pancreatic islet grafts, J. Surg. Res. 121 (2004) 141-150. (Pubitemid 39094108)
127. M.H. Zheng, H.L. Lin, L.X. Qiu, Y.L. Cui, Q.F. Sun, Y.P. Chen, Mixed microencapsulation of rat primary hepatocytes and Sertoli cells improves the metabolic function in a D-galactosamine and lipopolysaccharide-induced rat model of acute liver failure, Cytotherapy 11 (2009) 326-329.
128. G. Luca, M. Calvitti, C. Nastruzzi, L. Bilancetti, E. Becchetti, G. Angeletti, F. Mancuso, R. Calafiore, Encapsulation, in vitro characterization, and in vivo biocompatibility of Sertoli cells in alginate-based microcapsules, Tissue Eng. 13 (2007) 641-648. (Pubitemid 46579889)
129. G. Luca, M. Calvitti, F. Mancuso, G. Falabella, I. Arato, C. Bellucci, E.O. List, E. Bellezza, G. Angeli, C. Lilli, M. Bodo, E. Becchetti, J.J. Kopchick, D.F. Cameron, T. Baroni, R. Calafiore, Reversal of experimental Laron Syndrome by xenotransplantation of microencapsulated porcine Sertoli cells, J. Control. Release 165 (2013) 75-81.
130. G. Bistoni, M. Calvitti, F. Mancuso, I. Arato, G. Falabella, R. Cucchia, F. Fallarino, A. Becchetti, T. Baroni, S. Mazzitelli, C. Nastruzzi, M. Bodo, E. Becchetti, D.F. Cameron, G. Luca, R. Calafiore, Prolongation of skin allograft survival in rats by the transplantation of microencapsulated xenogeneic neonatal porcine Sertoli cells, Biomaterials 33 (2012) 5333-5340.
131. A. Goren, N. Dahan, E. Goren, L. Baruch, M. Machluf, Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy, FASEB J. 24 (2010) 22-31.
132. A. Garate, A. Murua, G. Orive, R.M. Hernandez, J.L. Pedraz, Stem cells in alginate bioscaffolds, Ther. Deliv. 3 (2012) 761-774.
133. J.L. Wilson, T.C. McDevitt, Stem cell microencapsulation for phenotypic control, bioprocessing, and transplantation, Biotechnol. Bioeng. (2012), http://dx.doi.org/ 10.1002/bit.24802.
134. J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, J.M. Jones, Embryonic stem cell lines derived from human blastocysts, Science 282 (1998) 1145-1147. (Pubitemid 28516247)
135. B.E. Tuch, T.C. Hughes, M.D.M. Evans, Encapsulated pancreatic progenitors derived from human embryonic stem cells as a therapy for insulin-dependent diabetes, Diabetes Metab. Res. 27 (2011) 928-932.
136. N. Wang, G. Adams, L. Buttery, F.H. Falcone, S. Stolnik, Alginate encapsulation technology supports embryonic stem cells differentiation into insulinproducing cells, J. Biotechnol. 144 (2009) 304-312.
137. S. Erceg, M. Ronaghi, M. Stojkovic, Human embryonic stem cell differentiation toward regional specific neural precursors, Stem Cells 27 (2009) 78-87.
138. J.J. Cunningham, T.M. Ulbright, M.F. Pera, L.H.J. Looijenga, Lessons from human teratomas to guide development of safe stem cell therapies, Nat. Biotechnol. 30 (2012) 849-857.
139. X. Fu, Y. Xu, Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability, Genome Med. 4 (2012) 55.
140. J.Y. Li, N.S. Christophersen, V. Hall, D. Soulet, P. Brundin, Critical issues of clinical human embryonic stem cell therapy for brain repair, Trends Neurosci. 31 (2008) 146-153.
141. S.C. Tobin, K. Kim, Generating pluripotent stem cells: differential epigenetic changes during cellular reprogramming, FEBS Lett. 586 (2012) 2874-2881.
142. S. Yamanaka, Induced pluripotent stem cells: past, present, and future, Cell Stem Cell 10 (2012) 678-684.
143. A. Heile, T. Brinker, Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagonlike peptide-1, Dialogues Clin. Neurosci. 13 (2011) 279-286.
144. D.J. Prockop, Marrow stromal cells as stem cells for nonhematopoietic tissues, Science 276 (1997) 71-74. (Pubitemid 27161245)
145. A. Van Damme, L. Thorrez, L. Ma, H. Vandenburgh, J. Eyckmans, F. Dell'Accio, C. De Bari, F. Luyten, D. Lillicrap, D. Collen, T. VandenDriessche, M.K. Chuah, Efficient lentiviral transduction and improved engraftment of human bonemarrowmesenchymal cells, Stem Cells 24 (2006) 896-907. (Pubitemid 44464723)
146. J.M. McMahon, S. Conroy, M. Lyons, U. Greiser, C. O'shea, P. Strappe, L. Howard, M. Murphy, F. Barry, T. O'Brien, Gene transfer into rat mesenchymal stemcells: a comparative study of viral and nonviral vectors, Stem Cells Dev. 15 (2006) 87-96.
147. A. Gebler, O. Zabel, B. Seliger, The immunomodulatory capacity of mesenchymal stem cells, Trends Mol. Med. 18 (2012) 128-134.
148. L. Zanotti, A. Sarukhan, E. Dander,M. Castor, J. Cibella, C. Soldani, A. Elisa Trovato, C. Ploia, G. Luca, M. Calvitti, F. Mancuso, I. Arato, M. Golemac, N. Jonjic, A. Biondi, R. Calafiore, M. Locati, G. D'Amico, A. Viola, Encapsulated mesenchymal stem cells for in vivo immunomodulation, Leukemia (2012), http://dx.doi.org/10.1038/ leu.2012.202.
149. F.P. Barry, J.M. Murphy, K. English, B.P. Mahon, Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft, Stem Cells Dev. 14 (2005) 252-265. (Pubitemid 40885249)
150. J.W. Yoo, D.J. Irvine, D.E. Discher, S. Mitragotri, Bio-inspired, bioengineered and biomimetic drug delivery carriers, Nat. Rev. Drug Discov. 10 (2011) 521-535.
151. M. Studeny, F.C. Marini, J.L. Dembinski, C. Zompetta, M. Cabreira-Hansen, B.N. Bekele, R.E. Champlin, M. Andreeff, Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents, J. Natl. Cancer Inst. 96 (2004) 1593-1603. (Pubitemid 39534883)
152. D.A. Kedziorek, L.V. Hofmann, Y. Fu, W.D. Gilson, K.M. Cosby, B. Kohl, B.P. Barnett, B.W. Simons, P. Walczak, J.W.M. Bulte, K. Gabrielson, D.L. Kraitchman, X-ray-visible microcapsules containing mesenchymal stem cells improve hind limb perfusion in a rabbit model of peripheral arterial disease, Stem Cells 30 (2012) 1286-1296.
153. S.J. Bidarra, C.C. Barrias, M.A. Barbosa, R. Soares, P.L. Granja, Immobilization of human mesenchymal stem cells within RGD-grafted alginate microspheres and assessment of their angiogenic potential, Biomacromolecules 11 (2010) 1956-1964.
154. Y. Man, P. Wang, Y. Guo, L. Xiang, Y. Yang, Y. Qu, P. Gong, L. Deng, Angiogenic and osteogenic potential of platelet-rich plasma and adipose-derived stem cell laden alginate microspheres, Biomaterials 33 (2012) 8802-8811.
155. P. Gir, G. Oni, S.A. Brown, A. Mojallal, R.J. Rohrich, Human adipose stem cells: current clinical applications, Plast. Reconstr. Surg. 129 (2012) 1277-1290.
156. C. Nie, D. Yang, S.F. Morris, Local delivery of adipose-derived stem cells via acellular dermal matrix as a scaffold: a new promising strategy to accelerate wound healing, Med. Hypotheses 72 (2009) 679-682.
157. W. Chen, H. Zhou, M.D.Weir, C. Bao, H.H.K. Xu, Umbilical cord stem cells released from alginate-fibrin microbeads inside macroporous and biofunctionalized calcium phosphate cement for bone regeneration, Acta Biomater. 8 (2012) 2297-2306.
158. K.J. Godfrey, B. Mathew, J.C. Bulman, O. Shah, S. Clement, G.I. Gallicano, Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells, Diabet. Med. 29 (2012) 14-23.
159. P. Montanucci, I. Pennoni, T. Pescara, P. Blasi, G. Bistoni, G. Basta, R. Calafiore, The functional performance of microencapsulated human pancreatic islet-derived precursor cells, Biomaterials 32 (2011) 9254-9262.
160. A. Acarregui, F.J. Blanco, R.M.Hernandez, J.L. PedrazMunoz,G. Orive,Hydrogel-based scaffolds for enclosing encapsulated therapeutic cells, Biomacromolecules (2012), http://dx.doi.org/10.1021/bm301690a.
161. T.F. Massoud, A. Singh, S.S. Gambhir, Noninvasive molecular neuroimaging using reporter genes: part I, principles revisited, AJNR Am. J. Neuroradiol. 29 (2008) 229-234. (Pubitemid 351287872)
162. D. Cheng, C. Lo, M.V. Sefton, Effect of mouse VEGF164 on the viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated cells in vivo: bioluminescence imaging, J. Biomed. Mater. Res. A 87 (2008) 321-331.
163. B.P. Barnett, A. Arepally, P.V. Karmarkar, D. Qian, W.D. Gilson, P. Walczak, V. Howland, L. Lawler, C. Lauzon, M. Stuber, D.L. Kraitchman, J.W. Bulte, Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells, Nat. Med. 13 (2007) 986-991. (Pubitemid 47222036)
164. B.P. Barnett, A. Arepally, M. Stuber, D.R. Arifin, D.L. Kraitchman, J.W. Bulte, Synthesis of magnetic resonance-, X-ray- and ultrasound-visible alginate microcapsules for immunoisolation and noninvasive imaging of cellular therapeutics, Nat. Protoc. 6 (2011) 1142-1151.
165. D.R. Arifin, D.A. Kedziorek, Y. Fu, K.W.Y. Chan, M.T. McMahon, C.R. Weiss, D.L. Kraitchman, J.W.M. Bulte, Microencapsulated cell tracking, NMR Biomed. (2012), http://dx.doi.org/10.1002/nbm.2894.
166. R. Catena, E. Santos, G. Orive, R.M. Hernández, J.L. Pedraz, A. Calvo, Improvement of the monitoring and biosafety of encapsulated cells using the SFGNESTGL triple reporter system, J. Control. Release 146 (2010) 93-98.
167. S.A. Bencherif, R.W. Sands, D. Bhatta, P. Arany, C.S. Verbeke, D.A. Edwards, D.J. Mooney, Injectable preformed scaffolds with shape-memory properties, Proc. Natl. Acad. Sci. 109 (2012) 19590-19595.
168. R.M. Olabisi, Z.W. Lazard, C.L. Franco, M.A. Hall, S.K. Kwon, E.M. Sevick-Muraca, J.A. Hipp, A.R. Davis, E.A. Olmsted-Davis, J.L. West, Hydrogel microsphere encapsulation of a cell-based gene therapy system increases cell survival of injected cells, transgene expression, and bone volume in a model of heterotopic ossification, Tissue Eng. A 16 (2010) 3727-3736.
169. M.T. Tomicic, R. Thust, B. Kaina, Ganciclovir-induced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation, Oncogene 21 (2002) 2141-2153. (Pubitemid 34311368)
170. E. Santos, L. Larzabal, A. Calvo, G. Orive, J.L. Pedraz, R.M. Hernandez, Inactivation of encapsulated cells and their therapeutic effects by means of TGL triple-fusion reporter/biosafety gene, Biomaterials 34 (2012) 1442-1451.
171. B. Ludwig, A. Rotem, J. Schmid, G.C. Weir, C.K. Colton, M.D. Brendel, T. Neufeld, N.L. Block, K. Yavriyants, A. Steffen, S. Ludwig, T. Chavakis, A. Reichel, D. Azarov, B. Zimermann, S. Maimon, M. Balyura, T. Rozenshtein, N. Shabtay, P. Vardi, K. Bloch, P. de Vos, A.V. Schally, S.R. Bornstein, U. Barkai, Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist, Proc. Natl. Acad. Sci. 109 (2012) 5022-5027.
172. H.J. Paek, A.B. Campaner, J.L. Kim, L. Golden, R.K. Aaron, D.M. Ciombor, J.R.Morgan, M.J. Lysaght, Microencapsulated cells genetically modified to overexpress human transforming growth factor-β1: viability and functionality in allogeneic and xenogeneic implant models, Tissue Eng. 12 (2006) 1733-1739. (Pubitemid 44162833)
173. E. Santos, G. Orive, A. Calvo, R. Catena, P. Fernández-Robredo, A.G. Layana, R.M. Hernández, J.L. Pedraz, Optimization of 100 μmalginate-poly-L-lysine-alginate capsules for intravitreous administration, J. Control. Release 158 (2012) 443-450.
174. S. Knippenberg, N. Thau, R. Dengler, T. Brinker, S. Petri, Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS, PLoS One 7 (2012) e36857.
175. H. He, E. Luedke, X. Zhang, B. Yu, A. Schmitt, V. Grignol, W.E. Carson III, L.J. Lee, A naonoporous cell-therapy device with controllable biodegradation for long-term drug release, J. Control. Release 165 (2012) 226-233.
176. B.M. Holzapfel, J.C. Reichert, J. Schantz, U. Gbureck, L. Rackwitz, U. Nöth, F. Jakob, M. Rudert, J. Groll, D.W. Hutmacher, How smart do biomaterials need to be? A translational science and clinical point of view, Adv. Drug Deliv. Rev. (2012), http://dx.doi.org/10.1016/j.addr.2012.07.009.
177. M. Tang, W. Chen, M.D. Weir, W. Thein-Han, H.H. Xu, Human embryonic stem cell encapsulation in alginate microbeads in macroporous calcium phosphate cement for bone tissue engineering, Acta Biomater. 8 (2012) 3436-3445.
178. S. Tendulkar, S.H. Mirmalek-Sani, C. Childers, J. Saul, E.C. Opara, M.K. Ramasubramanian, A three-dimensional microfluidic approach to scaling up microencapsulation of cells, Biomed. Microdevices 14 (2012) 461-469.
179. A. Murua, G. Orive, R.M. Hernandez, J.L. Pedraz, Cryopreservation based on freezing protocols for the long-term storage of microencapsulated myoblasts, Biomaterials 30 (2009) 3495-3501.
180. H. Hang, X. Shi, G.x. Gu, Y. Wu, J. Gu, Y. Ding, In vitro analysis of cryopreserved alginate-poly-L-lysine-alginate-microencapsulated human hepatocytes, Liver Int. 30 (2010) 611-622.
181. A. Sakai, F. Engelmann, Vitrification, encapsulation-vitrification and dropletvitrification: a review, Cryo-Letters 28 (2007) 151-172.
182. Y. Wu, H. Yu, S. Chang, R. Magalhaes, L.L. Kuleshova, Vitreous cryopreservation of cell-biomaterial constructs involving encapsulated hepatocytes, Tissue Eng. 13 (2007) 649-658. (Pubitemid 46579890)
183. E.T. Pashuck, M.M. Stevens, Designing regenerative biomaterial therapies for the clinic, Sci. Transl. Med. 4 (2012) 160sr4.
184. G.D. Prestwich, S. Bhatia, C.K. Breuer, S.L. Dahl, C. Mason, R. McFarland, D.J. McQuillan, J. Sackner-Bernstein, J. Schox, W.E. Tente, A. Trounson, What is the greatest regulatory challenge in the translation of biomaterials to the clinic? Sci. Transl. Med. 4 (2012) 160cm14.
185. V. Sahni, J.A. Kessler, Stem cell therapies for spinal cord injury, Nat. Rev. Neurol. 6 (2010) 363-372.
186. S. Wang, X. Qu, R.C. Zhao, Clinical applications of mesenchymal stem cells, J. Hematol. Oncol. 5 (2012), (19-8722-5-19).
187. J.C. Breger, D.B. Lyle, J.C. Shallcross, J.J. Langone, N.S. Wang, Defining critical inflammatory parameters for endotoxin impurity in manufactured alginate microcapsules, J. Biomed. Mater. Res. B Appl. Biomater. 91B (2009) 755-765.
188. J. Dusseault, S.K. Tam, M.Menard, S. Polizu, G. Jourdan, L. Yahia, J.P.Halle, Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination, J. Biomed. Mater. Res. A 76 (2006) 243-251.
189. P. de Vos, M.M. Faas, B. Strand, R. Calafiore, Alginate-based microcapsules for immunoisolation of pancreatic islets, Biomaterials 27 (2006) 5603-5617. (Pubitemid 44177795)
190. P. De Vos, B.J. De Haan, G.H. Wolters, J.H. Strubbe, R. Van Schilfgaarde, Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets, Diabetologia 40 (1997) 262-270. (Pubitemid 27096549)
191. P. de Vos, C.G. Hoogmoed, H.J. Busscher, Chemistry and biocompatibility of alginate-PLL capsules for immunoprotection of mammalian cells, J. Biomed. Mater. Res. 60 (2002) 252-259. (Pubitemid 34194586)
192. U. Leinfelder, F. Brunnenmeier, H. Cramer, J. Schiller, K. Arnold, J.A. Vásquez, U. Zimmermann, A highly sensitive cell assay for validation of purification regimes of alginates, Biomaterials 24 (2003) 4161-4172. (Pubitemid 36809018)
193. H. Zimmermann, S.G. Shirley, U. Zimmermann, Alginate-based encapsulation of cells: past, present, and future, Curr. Diab. Rep. 7 (2007) 314-320. (Pubitemid 47249091)
194. B. Sommer, C. Rinsch, E. Payen, B. Dalle, B. Schneider, N. Deglon, A. Henri, Y. Beuzard, P. Aebischer, Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts, Mol. Ther. 6 (2002) 155-161. (Pubitemid 36336122)
195. X. Zhao, J. Kim, C.A. Cezar, N. Huebsch, K. Lee, K. Bouhadir, D.J. Mooney, Active scaffolds for on-demand drug and cell delivery, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 67-72.